Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

Press releases published on June 5, 2026

Jun. 5, 2026

NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials

Indeterminate GlobeNewswire

Jun. 5, 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Indeterminate GlobeNewswire

Jun. 5, 2026

Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor…

Indeterminate GlobeNewswire

Jun. 5, 2026

Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth

Indeterminate GlobeNewswire

Jun. 5, 2026

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity

Indeterminate GlobeNewswire

Jun. 5, 2026

dLocal to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 5, 2026

SalesCloser Enters Global Hospitality Sector and Announces Engagement with Major North American Hotel

Indeterminate GlobeNewswire

Jun. 5, 2026

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 5, 2026

DBV Technologies participera à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire

Jun. 5, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire

Jun. 5, 2026

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire

Jun. 5, 2026

Alzai Health Corp. Announces TSX Venture Exchange Listing

Indeterminate GlobeNewswire

Jun. 5, 2026

Memocept Under Investigation: Shocking Memocept Brain Support Customer Complaints, Ingredient Claims, Effectiveness Questions, and Serious Side Effect Risks Examined

Indeterminate GlobeNewswire

Jun. 5, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

Indeterminate GlobeNewswire

Jun. 5, 2026

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Indeterminate GlobeNewswire

Jun. 5, 2026

Linkage Global Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Jun. 5, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire